Wei Liu

Wei Liu

Auto-generated profile, based on publicly available information

Wei Liu

Department of Encephalopathy, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250001, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SWShiying Wang
Shiying Wang
HWHuanmei Wang
Huanmei Wang
WLWei Liu
Wei Liu
BWBiaofang Wei
Biaofang Wei
Sex differences have been suggested to play critical roles in the pathophysiology of osteoarthritis (OA), resulting in sex-specific prevalence and incidence. However, their roles in the development of OA remain largely unknown. The aim of this study was to screen out key genes and pathways mediating biological differences between OA females after menopause and OA males. First, the gene expression data of GSE36700 and GSE55457 were downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) between sexes were identified using R software, respectively. The overlapping DEGs were obtained. Then, protein-protein interactive (PPI) network was constructed to further analyze interactions between the overlapping DEGs. Finally, enrichment analyses were separately performed using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes tools. In our results, a total of 278 overlapping DEGs were identified between OA females after menopause and OA males, including 219 upregulated and 59 downregulated genes. In the PPI network, seven hub genes were identified, including EGF, ERBB2, CDC42, PIK3R2, LCK, CBL, and STAT1. Functional enrichment analysis revealed that these genes were mainly enriched in PI3K-Akt signaling pathway, osteoclast differentiation, and focal adhesion. In conclusion, the results in the current study suggest that pathways of PI3K-Akt, osteoclast differentiation, and focal adhesion may play important roles in the development of OA females after menopause. EGFR, ERBB2, CDC42, and STAT1 may be key genes related to OA progression in postmenopausal women and may be promising therapeutic targets for OA.

30 April 2019 in BioMed Research International
Verified
Journal Article
Open access
WZWenhao Zhu
Wenhao Zhu
YNYinan Nan
Yinan Nan
SWShaoqing Wang
Shaoqing Wang
WLWei Liu
Wei Liu
Ischemic stroke (IS) is a complex disease with sex differences in epidemiology, presentations, and outcomes. However, the sex-specific mechanism underlying IS remains unclear. The purpose of this study was to identify key genes contributing to biological differences between sexes. First, we downloaded the gene expression data of GSE22255 from Gene Expression Omnibus (GEO). Differentially expressed genes (DEGs) were identified using R software and related packages. Second, DEGs were separately analyzed by Gene Ontology enrichment and pathways analyses. Third, protein-protein interaction (PPI) network was constructed to further investigate the interactions of DEGs. A total of 123 DEGs were identified between sexes, including 8 upregulated and 115 downregulated genes. In the PPI network, ten key genes were identified, including IL1α, IL1β, IL6, IL8, CXCL1, CXCL2, CXCL20, CCL4, ICAM1, and PTGS2. Functional enrichment analysis revealed that these genes were mainly enriched in biological processes of immune response and apoptotic process, also in pathways of TNF and NOD-like receptor signaling. In conclusion, the above ten genes may have a protective effect on IS females through their direct or indirect involvement in biological processes of immune response and apoptotic process, as well as in TNF and NOD-like receptor signaling pathways. The results of this study may help to gain new insights into the sex-specific mechanisms underlying IS females and may suggest potential therapeutic targets for disease treatment.

16 July 2021
Verified
Thesis
Closed access
CMClaire Elizabeth Martin
Claire Elizabeth Martin
ALAnthony M. Lowman
Anthony M. Lowman
KSKara L. Spiller
Kara L. Spiller
GZGuangdong Zhou
Guangdong Zhou
WLWei Liu
Wei Liu
Repair or regeneration of articular cartilage remains one of the most difficult challenges in orthopedic medicine. Poly(vinyl alcohol) (PVA) hydrogels have shown promise as synthetic cartilage replacement materials, especially those that allow sustained release of insulin-like growth factor 1 (IGF-1). The goal of this study was to increase the porosity of the previously designed hydrogels that had an average pore size of 60 to 100[mu]m and a porosity of 60 to 70%, while maintaining IGF-1 release in order to increase infiltration of chondrocytes from surrounding cartilage. The hydrogels were prepared using a previously established, single step, double emulsion technique based on a water-oil-water (W1/O/W2) composition. IGF-1 was encapsulated in degradable poly(lactic-co-glycolic acid) (PLGA) microparticles (W1/O) embedded in non-degradable poly(vinyl alcohol) (PVA) hydrogels (W2). The effects of processing parameters such as volume and composition of the water and oil phases were evaluated towards increasing hydrogel porosity. Hydrogels of various formulations had interconnected pores from 40 to 600um and average pore size of up to 337 ± 205[mu]m, and porosities of 76% to 84%, all of which were increases over the previous design. The controlled release system sustained release of IGF-1 for 73 days in vitro, with an initial burst on the first day of 1.82 ± 1.15[mu]g/ml. In order to study the controlled release of IGF-1 on cartilage tissue engineering in vivo, the hydrogels were seeded with chondrocytes and implanted subcutaneously into the backs of nude mice and harvested after two and five weeks in vivo. The introduction of high levels of porosity to PVA hydrogels resulted in a reduction in mechanical properties but an increase in cartilage growth within the hydrogels. This study shows that the sustained release of IGF-1 can enhance tissue formation within the pores of a non-degradable hydrogel. The increase in porosity of the IGF1-eluting hydrogels may improve implant integration with surrounding tissue.